1. Akpan I.N., Taskin T., Wheldon C.W., Rossheim M.E., Thompson E.L., Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States. Prev Med. 182: 107951, 2024. PMID38604575.
2. Atkins M.B., Jegede O.A., Haas N.B., McDermott D.F., Bilen M.A., Stein M., Sosman J., Alter R., Plimack E.R., Ornstein M.C., Hurwitz M., Peace D.J., Einstein D., Catalano P.J., Hammers H., Regan M.M., Treatment-free survival outcomes from the phase ii study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (hcrn gu16-260-cohort a). J Immunother Cancer. 12(4)2024. PMID38604810. PMC11015345.
3. Bagnyukova T., Egleston B.L., Pavlov V.A., Serebriiskii I.G., Golemis E.A., Borghaei H., Synergy of EGFR and AURKA inhibitors in KRAS-mutated non-small cell lung cancers. Cancer Res Commun, 2024. PMID38639476.
4. Balbach M.L., Neely G., Yorke A., Figueroa-Medina E., Paly J., Shulman R.M., Dempsey C., Shulman A., Biancia C.D., Cutrer W.B., Li B.C., Developing an educational “hub”: Impact of a distance-learning curriculum in a multinational cohort. BMC Med Educ. 24(1): 406, 2024. PMID38610008. PMC11010438.
5. Bamgbose G., Bordet G., Lodhi N., Tulin A., Mono-methylated histones control parp-1 in chromatin and transcription. Elife. 132024. PMID38690995.
6. Barata P., Gulati S., Elliott A., Hammers H.J., Burgess E.F., Gartrell B.A., Darabi S., Bilen M.A., Basu A., Geynisman D.M., Dawson N.A., Zibelman M.R., Zhang T., Wei S., Ryan C.J., Heath E.I., Poorman K.A., Nabhan C., McKay R.R., Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles. J Clin Invest, 2024. PMID38652565.
7. Bremner R.M., Ungerleider R.M., Ungerleider J., Wolf A.S., Erkmen C.P., Luc J.G.Y., Litle V.R., Cerfolio R.J.,Cooke D.T., Well-being of cardiothoracic surgeons in the time of covid-19: A survey by the wellness committee of the American association for thoracic surgery. Semin Thorac Cardiovasc Surg. 36(1): 129-136, 2024. PMID36244627.PMC9561391.
8. Budagyan K., Cannon A.C., Chernoff J., A facile method to append a bio-id tag to endogenous mutant kras alleles. Methods Mol Biol. 2797: 351-362, 2024. PMID38570472.
9. Bychkov I., Deneka A., Topchu I., Pangeni R., Ismail A., Lengner C., Karanicolas J., Golemis E., Makhov P., Boumber Y., Musashi-2 (msi2) regulation of DNA damage response in lung cancer. Res Sq, 2024. PMID38659828.PMC11042440. [Preprint]
10. Carril-Ajuria L., Lavaud P., Dalban C., Negrier S., Gravis G., Motzer R.J., Chevreau C., Tannir N.M., Oudard S., McDermott D.F., Laguerre B., Hammers H.J., Barthelemy P., Plimack E.R., Borchiellini D., Gross-Goupil M., Jiang R., Lee C.W., de Silva H., Rini B.I., Escudier B., Albigès L., Validation of the lung immune prognostic index (lipi) as a prognostic biomarker in metastatic renal cell carcinoma. Eur J Cancer. 204: 114048, 2024. PMID38653033.
11. Chen-Yost H.I., Bammert C., Hao W., Heymann J.J., Lin D.M., Marotti J., Waraksa-Deutsch T., Huang M., Krishnamurti U., Lin O., Ly A., Moatamed N., Pantanowitz L., Roy-Chowdhuri S., Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. J Am Soc Cytopathol, 2024. PMID38582697.
12. Chiba M., Shimono J., Suto K., Ishio T., Endo T., Goto H., Hasegawa H., Maeda M., Teshima T., Yang Y., Nakagawa M., Whole-genome CRISPR screening identifies molecular mechanisms of pd-l1 expression in adult t-cell leukemia/lymphoma. Blood. 143(14): 1379-1390, 2024. PMID38142436. PMC11033594.
13. Covington E.L., Suresh K., Anderson B.M., Barker M., Dess K., Price J.G., Moncion A., Vaccarelli M.J., Santanam L., Xiao Y., Mayo C., Perceptions on and roadblocks to implementation of standardized nomenclature in radiation oncology: A survey from tg-263u1. J Appl Clin Med Phys: e14359, 2024. PMID38689502.
14. Ditonno F., Veccia A., Montanaro F., Pettenuzzo G., Franco A., Manfredi C., Triggiani L., De Nunzio C., De Sio M., Cerruto M., Crivellaro S., Kutikov A., Autorino R., Antonelli A. Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: A systematic review and meta-analysis of comparative studies. BJU Int, 2024. PMID38622957.
15. Donovan B., Wiese D., Henry K.A., Wu J., Rae L. ,Anderson J., Evaluating the effects of food deserts and food swamps in an urban burn patient population. J Burn Care Res, 2024. PMID38630546.
16. Drevik J.A., Dalimov Z., Lucas J., Simhan J., Cohn J.A., Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantation. Int J Impot Res. 36(3): 201-205, 2024. PMID36198809.
17. Elkins M., Jain N., Tükel Ç., The menace within: Bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases. Curr Opin Microbiol. 79: 102473, 2024. PMID38608623.
18. Fried W., Tyagi M., Minakhin L., Chandramouly G., Tredinnick T., Ramanjulu M., Auerbacher W., Calbert M., Rusanov T., Hoang T., Borisonnik N., Betsch R., Krais J.J., Wang Y., Vekariya U.M., Gordon J., Morton G., Kent T., Skorski T., Johnson N., Childers W., Chen X.S., Pomerantz R.T., Discovery of a small-molecule inhibitor that traps polθ on DNA and synergizes with parp inhibitors. Nat Commun. 15(1): 2862, 2024. PMID38580648.PMC10997755.
19. Gautam A., Boyd D.F., Nikhar S., Zhang T., Siokas I., Van de Velde L.A., Gaevert J., Meliopoulos V., Thapa B., Rodriguez D.A., Cai K.Q., Yin C., Schnepf D., Beer J., DeAntoneo C., Williams R.M., Shubina M., Livingston B., Zhang D., Andrake M.D., Lee S., Boda R., Duddupudi A.L., Crawford J.C., Vogel P., Loch C., Schwemmle M., Fritz L.C., Schultz-Cherry S., Green D.R., Cuny G.D., Thomas P.G., Degterev A., Balachandran S., Necroptosis blockade prevents lung injury in severe influenza. Nature. 628(8009): 835-843, 2024. PMID38600381.
20. Gerber D.E., Wang Y., Ramalingam S.S., Bhalla S., Sun Z., Borghaei H., Brahmer J.R., Schiller J.H., Incidence, correlates, and prognostic significance of mixed response in advanced non-small cell lung cancer. Oncologist. 29(4): 342-349, 2024. PMID38207008. PMC10994259.
21. Hall M.J., D’Avanzo P.A., Chertock Y., Kelly P.J.A., Brajuha J., Singley K., Luck C.C., Bass S.B., Oncologists’ perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients. BMC Cancer. 24(1): 412, 2024. PMID38566032. PMC10988900.
22. Hayakawa K., Zhou Y., Shinton S.A., B-1 derived anti-thy-1 b cells in old aged mice develop lymphoma/leukemia with high expression of cd11b and hamp2 that different from tcl1 transgenic mice. Immun Ageing. 21(1): 22, 2024. PMID38570827. PMC10988983.
23. Hayek H., Rehbini O., Kosmider B., Brandt T., Chatila W., Marchetti N., Criner G.J., Bolla S., Kishore R., Bowler R.P., Bahmed K., The regulation of fatty acid synthase by exosomal mir-143-5p and mir-342-5p in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 70(4): 259-282, 2024. PMID38117249.
24. Hildebrand E.M., Polovnikov K., Dekker B., Liu Y., Lafontaine D.L., Fox A.N., Li Y., Venev S.V., Mirny L.A., Dekker J., Mitotic chromosomes are self-entangled and disentangle through a topoisomerase-ii-dependent two-stage exit from mitosis. Mol Cell. 84(8): 1422-1441.e14, 2024. PMID38521067.
25. Hussen A.S., Kravitz H.L., Freudenthal B.D., Whitaker A.M., Oxidative DNA damage on the VEGF G-quadruplex forming promoter is repaired via long-patch BER. Environ Mol Mutagen. 65 Suppl 1(Suppl 1): 25-39, 2024. PMID37606505. PMC10984112.
26. Im E.O., Chee W., Paul S., Choi M.Y., Kim S.Y., Yeo S., Ulrich C.M., Schapira M.M., Nguyen G.T., Meghani S., Mao J.J., Ma G., Inouye J., Deatrick J.A., Shin D., Bao T. Five dimensions of needs for help: The efficacy of a technology-based intervention among Asian American breast cancer survivors. J Cancer Educ, 2024. PMID38594385.
27. Ioffe D., McSweeny M., Hall M.J., Precision medicine in the era of genetic testing: Microsatellite instability evolved. Clin Colon Rectal Surg. 37(3): 157-171, 2024. PMID38617845. PMC11007599.
28. Jain S., Bakolitsa C., Brenner S.E., Radivojac P., Moult J., Repo S., Hoskins R.A., Andreoletti G., Barsky D., Chellapan A., Chu H.Y., Dabbiru N., Kollipara N.K., Ly M., Neumann A.J., Pal L.R., Odell E., Pandey G., Peters-Petrulewicz R.C., Srinivasan R., Yee S.F., Yeleswarapu S.J., Zuhl M., Adebali O., Patra A., Beer M.A., Hosur R., Peng J., Bernard B.M., Berry M., Dong S.C., Boyle A.P., Adhikari A., Chen J.Q., Hu Z.Q., Wang R., Wang Y.Q., Miller M., Wang Y.R., Bromberg Y., Turina P., Capriotti E., Han J.J., Ozturk K., Carter H., Babbi G., Bovo S., Di Lena P., Martelli P.L., Savojardo C., Casadio R., Cline M.S., De Baets G., Bonache S., Díez O., Gutiérrez-Enríquez S., Fernández A., Montalban G., Ootes L., Özkan S., Padilla N., Riera C., De la Cruz X., Diekhans M., Huwe P.J., Wei Q., Xu Q.F., Dunbrack R.L., Gotea V., Elnitski L., Margolin G., Fariselli P., Kulakovskiy I.V., Makeev V.J., Penzar D.D., Vorontsov I.E., Favorov A.V., Forman J.R., Hasenahuer M., Fornasari M.S., Parisi G., Avsec Z., Celik M.H., Nguyen T.Y.D., Gagneur J., Shi F.Y., Edwards M.D., Guo Y.C., Tian K., Zeng H.Y., Gifford D.K., Göke J., Zaucha J., Gough J., Ritchie G.R.S., Frankish A., Mudge J.M., Harrow J., Young E.L., Yu Y., Huff C.D., Murakami K., Nagai Y., Imanishi T., Mungall C.J., Jacobsen J.O.B., Kim D., Jeong C.S., Jones D.T., Li M.J., Guthrie V.B., Bhattacharya R., Chen Y.C., Douville C., Fan J., Kim D., Masica D., Niknafs N., Sengupta S., Tokheim C., Turner T.N., Yeo H.T.G., Karchin R., Shin S., Welch R., Keles S., Li Y., Kellis M., Corbi-Verge C., Strokach A.V., Kim P.M., Klein T.E., Mohan R., Sinnott-Armstrong N.A., Wainberg M., Kundaje A., Gonzaludo N., Mak A.C.Y., Chhibber A., Lam H.Y.K., Dahary D., Fishilevich S., Lancet D., Lee I., Bachman B., Katsonis P., Lua R.C., Wilson S.J., Lichtarge O., Bhat R.R., Sundaram L., Viswanath V., Bellazzi R., Nicora G., Rizzo E., Limongelli I., Mezlini A.M., Chang R., Kim S., Lai C., O’Connor R., Topper S., van den Akker J., Zhou A.Y., Zimmer A.D., Mishne G., Bergquist T.R., Breese M.R., Guerrero R.F., Jiang Y.X., Kiga N., Li B., Mort M., Pagel K.A., Pejaver V., Stamboulian M.H., Thusberg J., Mooney S.D., Teerakulkittipong N., Cao C., Kundu K., Yin Y.Z., Yu C.H., Kleyman M., Lin C.F., Stackpole M., Mount S.M., Eraslan G., Mueller N.S., Naito T., Rao A.R., Azaria J.R., Brodie A., Ofran Y., Garg A., Pal D., Hawkins-Hooker A., Kenlay H., Reid J., Mucaki E.J., Rogan P.K., Schwarz J.M., Searls D.B., Lee G.R., Seok C., Kramer A., Shah S., Huang C.V., Kirsch J.F., Shatsky M., Cao Y., Chen H.R., Karimi M., Moronfoye O., Sun Y.F., Shen Y., Shigeta R., Ford C.T., Nodzak C., Uppal A., Shi X.H., Joseph T., Kotte S., Rana S., Rao A., Saipradeep V.G., Sivadasan N., Sunderam U., Stanke M., Su A., Adzhubey I., Jordan D.M., Sunyaev S., Rousseau F., Schymkowitz J., Van Durme J., Tavtigian S.V., Carraro M., Giollo M., Tosatto S.C.E., Adato O., Carmel L., Cohen N.E., Fenesh I., Holtzer I., Juven-Gershon T., Unger R., Niroula A., Olatubosun A., Valiaho J., Yang Y., Vihinen M., Wahl M.E., Chang B., Chong K.C., Hu I., Sun R., Wu W.K.K., Xia X.X., Zee B.C., Wang M.H., Wang M., Wu C.L., Lu Y.T., Chen K., Yang Y.D., Yates C.M., Kreimer A., Yan Z.X., Yosef N., Zhao H.Y., Wei Z.P., Yao Z.M., Zhou F.F., Folkman L., Zhou Y.Q., Daneshjou R., Altman R.B., Inoue F., Ahituv N., Arkin A.P., Lovisa F., Bonvini P., Bowdin S., Gianni S., Mantuano E., Minicozzi V., Novak L., Pasquo A., Pastore A., Petrosino M., Puglisi R., Toto A., Veneziano L., Chiaraluce R., Ball M.P., Bobe J.R., Church G.M., Consalvi V., Mort M., Cooper D.N., Buckley B.A., Sheridan M.B., Cutting G.R., Scaini M.C., Cygan K.J., Fredericks A.M., Glidden D.T., Neil C., Rhine C.L., Fairbrother W.G., Alontaga A.Y., Fenton A.W., Matreyek K.A., Starita L.M., Fowler D.M., Löscher B.S., Franke A., Adamson S.I., Graveley B.R., Gray J.W., Malloy M.J., Kane J.P., Kousi M., Katsanis N., Schubach M., Kircher M., Tang P.L.F., Kwok P.Y., Lathrop R.H., Clark W.T., Yu G.Y.K., LeBowitz J.H., Benedicenti F., Bettella E., Bigoni S., Cesca F., Mammi I., Marino-Bus-Ije C., Milani D., Peron A., Polli R., Sartori S., Stanzial F., Ioldo I., Turolla L., Aspromonte M.C., Bellini M., Leonardi E., Liu X.M., Marshall C., McCombie W.R., Elefanti L., Menin C., Meyn M.S., Murgia A., Nadeau K.C.Y., Neuhausen S.L., Nussbaum R.L., Pirooznia M., Potash J.B., Dimster-Denk D.F., Rine J.D., Sanford J.R., Snyder M., Tavtigian S.V., Cole A.G., Sun S., Verby M.W., Weile J., Roth F.P., Tewhey R., Sabeti P.C., Campagna J., Refaat M.M., Wojciak J., Grubb S., Schmitt N., Shendure J., Spurdle A.B., Stavropoulos D.J., Walton N.A., Zandi P.P., Ziv E., Burke W., Chen F., Carr L.R., Martinez S., Paik J., Harris-Wai J., Yarborough M., Fullerton S.M., Koenig B.A., McInnes G., Shigaki D., Chandonia J.M., Furutsuki M., Kasak L., Yu C.H., Chen R., Cline M.S., Pandey G., Friedberg I., Getz G.A., Cong Q., Kinch L.N., Zhang J., Grishin N.V., Voskanian A., Kann M.G., Clark W.T., Tran E., Ioannidis N.M., Hunter J.M., Udani R., Cai B.H., Morgan A.A., Sokolov A., Stuart J.M., Tavtigian S.V., Minervini G., Monzon A.M., Batzoglou S., Butte A.J., Church G.M., Greenblatt M.S., Hart R.K., Hernandez R., Hubbard T.J.P., Kahn S., O’Donnell-Luria A., Ng P.C., Shon J., Tavtigian S.V., Veltman J., Zook J.M.,Critical Assessment G., Cagi, the critical assessment of genome interpretation, establishes progress and prospects for computational genetic variant interpretation methods. Genome Biology. 25(1): 53, 2024. PMC10882881.
29. Jermakowicz A.M., Kurimchak A.M., Johnson K.J., Bourgain-Guglielmetti F., Kaeppeli S., Affer M., Pradhyumnan H., Suter R.K., Walters W., Cepero M., Duncan J.S., Ayad N.G., RAPID resistance to bet inhibitors is mediated by FGFR1 in glioblastoma. Sci Rep. 14(1): 9284, 2024. PMID38654040.PMC11039727.
30. Jog A., Strauss Starling A.L., Kaur I., Um K., Keele L.J., Triggs J.R., Altieri M.S., Shao J.M., Paraesophageal hernia recurrence following repair: Making the case for reoperative surgery in a propensity-matched cohort. Surg Endosc, 2024. PMID38627258.
31. Johnson N., Surviving without brca2: Mlh1 gets r-looped in to curtail genomic instability. Journal of Clinical Investigation. 134(7)2024. WOS:001198702600004. PMC10977974.
32. Kadariya Y., Sementino E., Ruan M., Cheung M., Hadikhani P., Osmanbeyoglu H.U., Klein-Szanto A.J., Cai K.,Testa J.R., Low exposures to amphibole or serpentine asbestos in germline bap1-mutant mice induce mesothelioma characterized by an immunosuppressive tumor microenvironment. Cancer Res Commun. 4(4): 1004-1015, 2024. PMID38592450. PMC11000687.
33. Kakish H., Sun J., Ammori J.B., Hoehn R.S., Rothermel L.D., First-line immunotherapy for metastatic merkel cell carcinoma: Analysis of real-world survival data and practice patterns. Am J Clin Oncol, 2024. PMID38587336.
34. Lu Q., Kou D., Lou S., Ashrafizadeh M., Aref A.R., Canadas I., Tian Y., Niu X., Wang Y., Torabian P., Wang L., Sethi G., Tergaonkar V., Tay F., Yuan Z., Han P., Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J Hematol Oncol. 17(1): 16, 2024. PMID38566199. PMC10986145.
35. Mischley V., Maier J., Chen J., Karanicolas J., Ppiscreenml: Structure-based screening for protein-protein interactions using alphafold. bioRxiv 2024. PMID38559274. PMC10979958. [Preprint]
36. Neal J.W., Minichiello K., Brennick R., Huang R.S.P., Hiemenz M.C., Amler C., Patel J., Herbst R., Reckamp K.L., Borghaei H., Highleyman L., Redman M.W., Pasquina L.W., Kozono D.E., A process to reanalyze clinical DNA sequencing data for biomarker matching in the lung-map master protocol. Oncologist, 2024. PMID38597608.
37. Nguyen T., Carrieri F.A., Connis N., Lafargue A., Chang J., Chan A., Shetty A.C., Song Y., Hoang T., Jagtap S., Chowdhury D.D., Khan M.A., Gabrielson K.L., Rezaee M., Torres-Ayuso P., Brognard J., Hann C.L., Tran P.T., TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapy. Mol Cancer Ther, 2024. PMID38670554.
38. Punjabi A., Araya S., Amadio G., Webster T., Mutyala S., Wu M., Zhao H., Roth S., Walchak A., Patel S.A., Chimeric versus multiple flaps for composite oral cavity defects: A systematic review and meta-analysis. Laryngoscope, 2024. PMID38689522.
39. Purdue M.P., Dutta D., Machiela M.J., Gorman B.R., Winter T., Okuhara D., Cleland S., Ferreiro-Iglesias A., Scheet P., Liu A., Wu C., Antwi S.O., Larkin J., Zequi S.C., Sun M., Hikino K., Hajiran A., Lawson K.A., Cárcano F., Blanchet O., Shuch B., Nepple K.G., Margue G., Sundi D., Diver W.R., Folgueira M., van Bokhoven A., Neffa F., Brown K.M., Hofmann J.N., Rhee J., Yeager M., Cole N.R., Hicks B.D., Manning M.R., Hutchinson A.A., Rothman N., Huang W.Y., Linehan W.M., Lori A., Ferragu M., Zidane-Marinnes M., Serrano S.V., Magnabosco W.J., Vilas A., Decia R., Carusso F., Graham L.S., Anderson K., Bilen M.A., Arciero C., Pellegrin I., Ricard S., Scelo G., Banks R.E., Vasudev N.S., Soomro N., Stewart G.D., Adeyoju A., Bromage S., Hrouda D., Gibbons N., Patel P., Sullivan M., Protheroe A., Nugent F.I., Fournier M.J., Zhang X., Martin L.J., Komisarenko M., Eisen T., Cunningham S.A., Connolly D.C., Uzzo R.G., Zaridze D., Mukeria A., Holcatova I., Hornakova A., Foretova L., Janout V., Mates D., Jinga V., Rascu S., Mijuskovic M., Savic S., Milosavljevic S., Gaborieau V., Abedi-Ardekani B., McKay J., Johansson M., Phouthavongsy L., Hayman L., Li J., Lungu I., Bezerra S.M., Souza A.G., Sares C.T.G., Reis R.B., Gallucci F.P., Cordeiro M.D., Pomerantz M., Lee G.M., Freedman M.L., Jeong A., Greenberg S.E., Sanchez A., Thompson R.H., Sharma V., Thiel D.D., Ball C.T., Abreu D., Lam E.T., Nahas W.C., Master V.A., Patel A.V., Bernhard J.C., Freedman N.D., Bigot P., Reis R.M., Colli L.M., Finelli A., Manley B.J., Terao C., Choueiri T.K., Carraro D.M., Houlston R., Eckel-Passow J.E., Abbosh P.H., Ganna A., Brennan P., Gu J.,Chanock S.J., Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet, 2024. PMID38671320.
(Read the NIH news release here: https://www.nih.gov/news-events/news-releases/analysis-identifies-50-new-genomic-regions-associated-kidney-cancer-risk
40. Quinteros S.L., Snyder N.W., Chatoff A., Ryan F., O’Brien B.,Donnelly S., The helminth-derived peptide, fhhdm-1, reverses the trained phenotype of nod bone-marrow-derived macrophages and regulates proinflammatory responses. Eur J Immunol: e2350643, 2024. PMID38581085.
41. Reese J.B., Bauman J.R., Sorice K.A., Frederick N., Bober S.L., Reply to S.S. Coughlin et al. JCO Oncol Pract: Op2400202, 2024. PMID38608216.
42. Rodrigues G., Higgins K.A., Rimner A., Amini A., Chang J.Y., Chun S.G., Donington J., Edelman M.J., Gubens M.A., Iyengar P., Movsas B., Ning M.S., Park H.S., Wolf A., Simone C.B., 2nd, American radium society appropriate use criteria for unresectable locally advanced non-small cell lung cancer. JAMA Oncol, 2024. PMID38602670.
43. Rodriguez A.L., Cappelletti L., Kurian S.M., Passio C., Rux S. Transitional care navigation. Semin Oncol Nurs. 40(2): 151580, 2024. PMID38290928.
44. Sadeghi J.K., Reza J.A., Miller C., Cooke D.T., Erkmen C., Death by a thousand delays. JTCVS Open. 18: 353-359, 2024. PMID38690410. PMC11056460.
45. Sedrak M.S., Sun C.L., Bae M., Freedman R.A., Magnuson A., O’Connor T., Moy B., Wildes T.M., Klepin H.D., Chapman A.E., Tew W.P., Dotan E., Fenton M.A., Kim H., Katheria V., Muss H.B., Cohen H.J., Gross C.P., Ji J., Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: Results from the hurria older patients (hope) prospective study. J Cancer Surviv, 2024. PMID38678525.
46. Siminoff L.A., Wilson-Genderson M., Chwistek M.,Thomson M., The cancer caregiving burden trajectory over time: Varying experiences of perceived versus objectively measured burden. Oncologist, 2024. PMID38652165.
47. Skiendzielewski K., Forke C.M., Sarwer D.B., Noll J.G., Wheeler D.C., Henry K.A., Schroeder K., The intersection of adverse childhood experiences and neighborhood determinants of health: An exploratory spatial analysis. Psychol Trauma. 16(Suppl 1): S125-s132, 2024. PMID35834220. PMC9839886.
48. Stutzmann G.E., Soboloff J. Channelling calcium signals to therapeutics. J Physiol. 602(8): 1445-1447, 2024. PMID38578234.
49. Tangudu N.K., Buj R., Wang H., Wang J., Cole A.R., Uboveja A., Fang R., Amalric A., Yang B., Chatoff A., Crispim C.V., Sajjakulnukit P., Lyons M.A., Cooper K., Hempel N., Lyssiotis C.A., Chandran U.R., Snyder N.W., Aird K.M., De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer Res Commun, 2024. PMID38626341.
50. Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., Correction: Standardization of colon resection for cancer: An overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2024. PMID38662097.
51. Tiger Y.K.R., Jain S., Barta S.K., Tolu S., Estrella B., Sawas A., Lue J.K., Francescone M.M., Pro B., Amengual J.E., Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature t-cell lymphoma. Leukemia & Lymphoma: 1-10, 2024. WOS:001189458100001.
52. Wasik M.A., Kim P.M., Nejati R. Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: Pathogenetic insights and translational implications. Front Oncol. 14: 1383741, 2024. PMID38638855. PMC11024630.
53. Wei S., Pei J., Belser P., Lee T., Farma J.M., Patchefsky A.S., Flieder D.B., Montgomery E.A., Novel mir143hg::Plag1 gene fusion identified in a rectal myxoid leiomyosarcoma. Genes Chromosomes Cancer. 63(4): e23239, 2024. PMID38656544.
54. Wheldon C.W., Skurka C., Eng N., Inoculating Black/African American and LGBTQ communities against the tobacco industry: The role of community connectedness and tobacco denormalization beliefs. Health Promot Pract. 25(3): 445-454, 2024. PMID36648060.
55. Xiang A., Braun A.E., Chang C., Swerdloff D., Gross M.S., Simhan J., Penoscrotal inflatable penile prosthesis recipients often fully recover from pain at two weeks following placement. Int J Impot Res, 2024. PMID38561424.
56. Yang S., Li Y., Wheldon C.W., Prosperi M., George T.J., Shenkman E.A., Wang F., Bian J.,Guo Y., The burden of cancer and pre-cancerous conditions among transgender individuals in a large healthcare network. medRxiv, 2024. PMID38585849. PMC10996763. [Preprint]
57. Yankey H., Ruth K.J., Dotan E., Reddy S., Meyer J.E., Survival and toxicity in patients with unresectable or inoperable biliary tract cancers with ablative radiation therapy versus nonablative chemoradiation. Advances in Radiation Oncology. 9(4)2024. WOS:001188630500001.
58. Zarrabi K.K., Miron B., Geynisman D.M., Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the javelin bladder 100 comprehensive clinical subgroup analyses. Transl Androl Urol. 13(3): 463-466, 2024. PMID38590958. PMC10999025.
59. Zhao J., Reese J.B., Han X., Yabroff K.R. Loneliness and mortality risk among cancer survivors in the United States: A retrospective, longitudinal study. J Natl Compr Canc Netw: 1-5, 2024. PMID38663443.
talbotresearchlibrary.wordpress.com 